Neoadjuvant immunotherapy improves outcomes in high-risk melanoma patients.

Published Date: 02 Mar 2023

High-risk melanoma patients who received the drug pembrolizumab before or after surgery to remove the cancer had a higher risk of developing melanoma than those who did not have a similar condition that eliminated cancer cells.

Read Full News

Latest News

Exclusive-South Carolina Seeks Non-CDC Reinforcements to Contain Growing Measles Outbreak

A dozen public health experts are arriving in South Carolina to help the state contain the largest U.S. measles outbreak in more than 30 years, but they're not coming from...

BMI Shapes Oxytocin Needs in Labor Induction

Individuals receiving maximum oxytocin doses have elevated risk for cesarean delivery and postpartum hemorrhage, but the risks are attenuated in those with elevated BMI.

Match Making Made Easy: ‘Take a Deep Breath’

Med students have until March 4 to finalize their Match lists. There is a lot to consider before then.

How These Doctors Fight the Social Media Trust War

As trust in healthcare erodes and disinformation thrives on social media, a small but determined group of physicians wants to win.

FDA Approves New Narcan Packaging, Aiming to Boost Carry Rates

FDA Approves New Narcan Packaging, Aiming to Boost Carry Rates

FDA Approves Tradipitant (NEREUS) for the Prevention of Vomiting Induced by Motion

FDA Approves Tradipitant (NEREUS) for the Prevention of Vomiting Induced by Motion

Todays Updates

Treating Depression: Crucial for Recovery From Fibromyalgia

In patients with newly diagnosed fibromyalgia who have prominent symptoms of anxiety and depression, remission of depression — not pain reduction alone — determines clinical improvement.

The Boom in ADHD Coaching Has Few Rules

Most ADHD coaches do not have behavioral health training, a study finds, but experts say peer support can help people navigate living with the condition.

SBRT May Beat Brachytherapy in Prostate Cancer

In the long term, stereotactic body radiotherapy carries a lower risk for biochemical failure vs high-dose rate brachytherapy for men with intermediate-risk prostate cancer.

Todays Updates

Treating Depression: Crucial for Recovery From Fibromyalgia

In patients with newly diagnosed fibromyalgia who have prominent symptoms of anxiety and depression, remission of depression — not pain reduction alone — determines clinical improvement.

The Boom in ADHD Coaching Has Few Rules

Most ADHD coaches do not have behavioral health training, a study finds, but experts say peer support can help people navigate living with the condition.

SBRT May Beat Brachytherapy in Prostate Cancer

In the long term, stereotactic body radiotherapy carries a lower risk for biochemical failure vs high-dose rate brachytherapy for men with intermediate-risk prostate cancer.

Latest News

A dozen public health experts are arriving in South Carolina to help the state contain the largest U.S. measles outbreak in more than 30 years, but they're not coming from...

Individuals receiving maximum oxytocin doses have elevated risk for cesarean delivery and postpartum hemorrhage, but the risks are attenuated in those with elevated BMI.

Med students have until March 4 to finalize their Match lists. There is a lot to consider before then.

As trust in healthcare erodes and disinformation thrives on social media, a small but determined group of physicians wants to win.

FDA Approves New Narcan Packaging, Aiming to Boost Carry Rates

FDA Approves Tradipitant (NEREUS) for the Prevention of Vomiting Induced by Motion

News All Time

Icotrokinra beneficial for adults, teens with plaque psoriasis

For adults and adolescents with moderate-to-severe plaque psoriasis, selective blockade of the interleukin-23 receptor with the targeted oral peptide icotrokinra yields a significantly higher incidence of skin clearance at ...

Researchers try bold new approach in a race to better treat autoimmune diseases

Scientists are trying a revolutionary new approach to treat rheumatoid arthritis, multiple sclerosis, lupus and other devastating autoimmune diseases—by reprogramming patients' out-of-whack immune systems.

Gut bacterium may sabotage liver cancer immunotherapy, study suggests

A research team led by the Department of Clinical Oncology, Center of Cancer Medicine, School of Clinical Medicine, LKS Faculty of Medicine, the University of Hong Kong (HKUMed), has identified a critical factor contributing ...

Cellular protein FGD3 boosts breast cancer chemotherapy and immunotherapy, study finds

A naturally-occurring protein that tends to be expressed at higher levels in breast cancer cells boosts the effectiveness of some anticancer agents, including doxorubicin, one of the most widely used chemotherapies, and a ...

Immune reactions found behind human rejection of transplanted pig kidneys

Researchers have uncovered and then overcome an obstacle that has led to the failure of pioneering efforts in xenotransplantation, in which an animal kidney is transplanted into a human.

Common cold virus may unlock better COVID vaccine

Prior exposure to coronaviruses that cause ordinary colds can boost the immune system's ability to attack a vulnerable site on the COVID-19-causing coronavirus SARS-CoV-2, according to a study led by investigators at Weill ...

Global reviews call for urgent action on endometriosis in most world regions

Two reviews published in The Lancet Obstetrics, Gynecology & Women's Health reveal stark global inequities in how endometriosis is recognized, treated, and prioritized in national health systems.

Study tracking how tumor microenvironment develops signals opportunity for early detection, risk prediction

Colorectal cancer precursor lesions are benign growths that can develop into colorectal cancer (CRC) over time, through either a conventional or serrated pathway. Understanding how the immune system reacts to these precursor ...

Flu vaccine performance varies by age, study reveals

New research comparing four different flu vaccines found that the ability of the vaccines to activate cells of the immune system that help to protect against infection varied greatly depending on the vaccine type and age ...

Mental and physical coaching before surgery prepares immune system and reduces complications, trial finds

The weeks leading up to a major surgery can be a time of uncertainty and worry for patients, many of whom anticipate the need for rehabilitation to get back on their feet. But if patients improve their physical and mental ...

Researchers aim to disrupt breast cancer line of communication and prevent spread

Cancer Center at Illinois (CCIL) Program Leader Erik Nelson's lab made an important discovery about the relationship between cholesterol and breast cancer progression with crucial implications for breast cancer therapeutics.

Rapid growth of radiopharmaceutical therapy highlights need for expertise

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has released a position paper outlining the education, training, and experience needed to ensure the safe and effective delivery of radiopharmaceutical therapy ...

Study reveals why some myeloma patients stay cancer-free for years after CAR T therapy

A new study from the Icahn School of Medicine at Mount Sinai helps explain why some people with multiple myeloma, a type of blood cancer, stay in remission for many years after receiving CAR T cell therapy, while others see ...

FDA grants fast track designation to drug combo for colorectal cancer

The U.S. Food and Drug Administration has granted Fast Track Designation to a new drug combination for metastatic colorectal cancer, following encouraging results from a clinical trial led in part by the University of Oklahoma ...

Newly identified lymphoma subtype gives hope in fight against aggressive form of blood cancer

Researchers at the University of Southampton have identified a new subtype of lymphoma that could pave the way to improved and more targeted treatments for some blood cancer patients. The cancer scientists and biologists ...

T cell therapies show long-term HPV gains

Researchers from Rutgers Cancer Institute, New Jersey's only National Cancer Institute (NCI)—designated Comprehensive Cancer Center, and RWJBarnabas Health, along with colleagues from the National Cancer Institute, a center ...

Recommended News For You

For cancer patients who are not responding to chemotherapy, new genes and natural toxins offer hope.

PSA Testing Is Not Enough for Another Candidate for Prostate Cancer Screening.

Nuclear missile workers are contracting cancer: They blame the bases

healthy despite having advanced cancer.

Researchers publish action plan to address appendiceal cancer enigmas

Year in Review: Multiple Myeloma

Prostate cancer relapse after radiotherapy is strongly predicted by biological markers.

Recommended Articles For You

Decoding the Failures in Acute Myeloid Leukemia Treatment: Mechanisms, Pathways, & Survival Outcomes 

Unlocking Immunity: TILs, Immunotherapy Biomarkers, and Toxicity Management in Oncology 

Neoadjuvant Radiotherapy & Endocrine Therapy in ER+ Breast Cancer Treatment 

Pediatric Oncology at the Cutting Edge: From Early Diagnosis to Lifesaving Therapies 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Surviving cancer, still suffering: Survey reveals gaps in follow‑up care

2.

Cancer mortality continuing to decline, says report

3.

Advances in TNBC; Mixed News in Lung Cancer Report; Pancreatic Cancer Overdiagnosis?

4.

Stereotactic Radiation Linked to Better Brain Mets Outcomes

5.

Pomalidomide Reduces Severe Epistaxis in Hereditary Bleeding Disease.

1.

Beyond the Human Eye: How AI Is Redefining Brain Cancer Diagnosis Through Advanced Imaging

2.

All You Need To Know About Melanoma Maligna: Causes, Symptoms & Treatment

3.

Navigating the Complexity of Peritoneal Carcinomatosis: A Guide for Patients and Caregivers

4.

Beyond Symptoms: The Predictive Promise of Targeted Radionuclide Therapy in Palliative Oncology

5.

Mitoxantrone–Napabucasin Co-Nanoformulation Activates cGAS-STING in HCC Therapy

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Navigating the Complexities of Ph Negative ALL - Part VI

2.

Navigating the Complexities of Ph Negative ALL - Part XIV

3.

CNS Clarity from Day One: Rethinking Early Diagnostic Strategies in ALK+NSCLC

4.

The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management- Further Discussion

5.

Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot